Bank Of America Corp Celularity Inc Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.17 - $0.33 $10 - $19	59 Added 1.34%	4,455 $1,000
Q2 2023 Aug 14, 2023	SELL	$0.42 - $0.81 $10,449 - $20,151	-24,879 Reduced 84.98%	4,396 $2,000
Q1 2023 May 12, 2023	SELL	$0.56 - $1.15 $11,493 - $23,602	-20,524 Reduced 41.21%	29,275 $18,000
Q4 2022 Feb 10, 2023	BUY	$1.08 - $2.35 $40,981 - $89,173	37,946 Added 320.14%	49,799 $64,000
Q3 2022 Nov 14, 2022	SELL	$0.43 - $4.31 $1,597 - $16,007	-3,714 Reduced 23.86%	11,853 $28,000
Q2 2022 Aug 12, 2022	SELL	$2.81 - $12.91 $19,192 - $88,175	-6,830 Reduced 30.5%	15,567 $52,000
Q1 2022 May 16, 2022	BUY	$3.81 - $9.79 $85,324 - $219,247	22,395 Added 1119750.0%	22,397 $195,000
Q4 2021 Feb 08, 2022	SELL	$4.64 - $7.46 $10,305 - $16,568	-2,221 Reduced 99.91%	2 $0
Q3 2021 Nov 15, 2021	BUY	$6.05 - $12.15 $13,449 - $27,009	2,223 New	2,223 $16,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.